Legacy Capital Group California, Inc.
Source: SEC Form 13F · as of Mar 2026Legacy Capital Group California, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $15.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$15.3M
| Company | Shares | Value |
|---|---|---|
| CAHCardinal Health Inc. | 9,850 | $2.1M |
| GMOptec International, Inc. | 19,692 | $1.5M |
| JNJJOHNSON & JOHNSON | 5,960 | $1.5M |
| MRKMerck & Co., Inc. | 10,684 | $1.3M |
| PFEPFIZER INC | 38,519 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,180 | $973K |
| BMYBRISTOL MYERS SQUIBB CO | 15,438 | $936K |
| AMGNAMGEN INC | 2,395 | $843K |
| ABTABBOTT LABORATORIES | 7,883 | $809K |
| GILDGILEAD SCIENCES, INC. | 4,159 | $580K |
| CORCencora Inc. | 1,795 | $564K |
| BIIBBIOGEN INC. | 2,901 | $532K |
| ROIVRoivant Sciences Ltd. | 16,553 | $459K |
| ARGXARGENX SE | 606 | $443K |
| NVONovo Nordisk A/S | 10,094 | $371K |
| AZNASTRAZENECA PLC | 1,781 | $351K |
| MEDPMedpace Holdings Inc. | 653 | $314K |
| ELANElanco Animal Health Inc | 12,480 | $299K |
| GMEDGlobus Medical Inc. | 2,754 | $237K |
| ZBHZimmer Biomet Holdings Inc. | 2,234 | $202K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.